Top Tweets for #persaf
#PersAF continues to be in the spotlight: Dr Venier, Dr @dogi84md & Dr Ventrella shared insight on their imaging best practices, while Dr @Drdevignair presented a recorded case with FARAPOINT™, our focal #PFA catheter, adding an extra tool to tackle ablation lines.
#NHAF2025
NEW CLINICAL DATA primary endpoints met!
ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients.
View the data below.
#PFALive #EPeepNEW CLINICAL DATA primary endpoints met!
ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients.
View the data below.
#PFALive #EPeepNEW CLINICAL DATA primary endpoints met!
ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients.
View the data below.
#PFALive #EPeepNEW CLINICAL DATA primary endpoints met!
ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients.
View the data below.
#PFALive #EPeepNEW CLINICAL DATA primary endpoints met!
ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients.
View the data below.
#PFALive #EPeeps
NEW CLINICAL DATA primary endpoints met! ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients. View the data below.
#PFALive #EPeepNEW CLINICAL DATA primary endpoints met! ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients. View the data below.
#PFALive #EPeepNEW CLINICAL DATA primary endpoints met! ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients. View the data below.
#PFALive #EPeepNEW CLINICAL DATA primary endpoints met! ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients. View the data below.
#PFALive #EPeepNEW CLINICAL DATA primary endpoints met! ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients. View the data below.
#PFALive #EPeepNEW CLINICAL DATA primary endpoints met! ADVANTAGE Phase II, presented by @VivekReddyMD showed positive results using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the treatment of #AFib in #PersAF patients. View the data below.
#PFALive #EPeeps
See our latest #PFA trial results presented at #AFSymposium25:
ADVANTAGE AF US IDE Clinical Trial primary safety and effectiveness endpoints were met for treating patients with persistent atrial fibrillation (#PersAF).
▪️ At 12 months, the primary safety event rate was 2.3% [5.1% UCL] which met the 12.0% performance goal, with no reported stroke, PV stenosis, esophageal fistula or major access complications.
▪️ At 12 months, the primary effectiveness rate was 63.5% [57.3% LCL] which met the acceptance criteria of 40.0%. The rate of patients free from documented symptomatic recurrence was 85.3%, which improved to 91.8% when operators performed three or more trial procedures.
View the full trial results: https://t.co/OixSUPJQfV
#Epeeps
![BSCCardiology's tweet photo. See our latest #PFA trial results presented at #AFSymposium25:
ADVANTAGE AF US IDE Clinical Trial primary safety and effectiveness endpoints were met for treating patients with persistent atrial fibrillation (#PersAF).
▪️ At 12 months, the primary safety event rate was 2.3% [5.1% UCL] which met the 12.0% performance goal, with no reported stroke, PV stenosis, esophageal fistula or major access complications.
▪️ At 12 months, the primary effectiveness rate was 63.5% [57.3% LCL] which met the acceptance criteria of 40.0%. The rate of patients free from documented symptomatic recurrence was 85.3%, which improved to 91.8% when operators performed three or more trial procedures.
View the full trial results: https://t.co/OixSUPJQfV
#Epeeps](https://pbs.twimg.com/media/Gh-tSyqXUAAezDy.jpg)
NEW CLINICAL DATA: The ADVANTAGE AF US IDE Clinical Trial met its safety and effectiveness endpoints for treating patients with persistent atrial fibrillation (#PersAF) with the FARAPULSE™ Pulsed Field Ablation System. Ablation treatment included both pulmonary vein isolation (PVI) and posterior wall ablation (PWA).
See detailed results here: https://t.co/iYfERz7kzd
#AFSymposium2025 #PulsedFieldAblation #EPeeps
#PVI is not blanket Rx for AF. We #EPeeps need to do a better job in identifying AF mechs on a patient to patient basis. Else, one would erroneously conclude dt #CBA is d best ablation modality for #PersAF @DrRoderickTung @narrowQRS @AZ_EP_DOC @aalahmadmd
https://t.co/5dTJuXvFzk
In this new #JACCCEP study, @ghaith_zaatari & #EPeeps from @UMiamiHealth find that electrogram morphology recurrence mapping for #PersAF provides a robust new method for quantifying consistency & rapidity of activation direction at multiple atrial sites. https://t.co/kclYNX8eJ2
#ACC23 #WCCardio #AFib #epAblation
.@Dominik_Linz:
Remember #PAF often *progresses* to #persAF or permanent #AFib: at least ~12%
✨Early rhythm control via ablation decreases progression of atrial fibrillation✨
https://t.co/O65uRVhRIO
PROGRESSIVE-AF from @DrJasonAndrade: https://t.co/aT7Qoid6XR
#WAFib2023
#PersAF
PVI vs. PVI + low voltage RFA or PW BOX
Same substrate different outcome based on CAPLA study and ERASE trial.
Casa done yesterday with @GusCostaEP57
CAS @e_mendo93
What is your approach?
Poll bellow.
@BiosenseWebster
Published just yesterday & already thought to upcoming #EPeeps on todays @EHRA Course on Advanced EP with focus on AF ablation by @TillAlthoff
#ERASEAF trial - RCT on PVI+ in #persAF @NEJMEvidence
https://t.co/XjDJpnvvXK…
@purerfellner @YanHuo2022 @Phiso_de @ThomasGaspar16
Galaxy Medical’s CENTAURI PEF System – the newest upgrade in safe & durable ablation technology.
#GalaxyMedical #Cardiology #Electrophysiology #EPLab #CardioTwitter #EPeeps #Afib #PersAF #PAF #Arrhythmias #AFIB #AtrialFibrillation #AtrialFlutter #CardiacAblation #CardioEd
DECAAF II trial now online @JAMANetwork! Absolutely thrilled to be a part of this incredible work! #PVI alone still prevails in ablation of #persAF. https://t.co/bRFKXdTI9y @nmarrouche @TulaneTriad
#WomeninEP in CGN. Isabel Deisenhofer on #persAF @micaela_ebert @rukenakbulak @ViclouiseJ @giuliavogler Great to have you here. #DASCAM #AcademyESC
An explosion of AF ablation?🙂
It depends on how it's sold:
1. Success rate
2. Complications
3. Impact of conservative therapy (...for #PersAF, even a switch to digoxin?!!)
Are you an advocate of early AF trigger elimination by ablation, or other, more subtle means? #ESCCongress
#ESCCongress seems to me that there will be an explosion of AF ablation in pts with PAF / Perisistent AF with new guideline recommendations - are we being too liberal? @escardio @drjohnm @DrAfzalSohaib @purviparwani @majazayeri @rbcasado @onco_cardiology @aayshacader @HanCardiomd
On PW isolation. Linear ablation is often considered challenging. This is what we see most days. 2 consecutive pts: PWI is achieved with 3 (roof, Fig1) & 1 (inf@line Fig2) RF lesions in pt1 (#PAF) & spont roof block + 1 lesion (inf line Fig3) in pt 2 (#PersAF). #EPeeps #TactiCath
Last Seen Hashtags on Sotwe
سكُُس_عرُُُبي_جديد
Seen from Algeria
tnigay
Seen from Indonesia
nolimits teen
Seen from Australia
ديوت_بدوي
Seen from Brazil
AmongusNSfW
Seen from Ukraine
PRAGMATA
Seen from United States
รับงานรามคําแหง
Seen from Thailand
mallugirls
Seen from India
pyttwerk
Seen from United States
dramakoreaterbaru
Seen from Indonesia
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.6M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.7M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.7M followers
Taylor Swift
@taylorswift13
81.5M followers
Lady Gaga
@ladygaga
73.1M followers
Virat Kohli
@imvkohli
69.9M followers
Kim Kardashian
@kimkardashian
69.8M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.9M followers
Neymar Jr
@neymarjr
62.7M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.8M followers